Cargando…
Post-Marketing Surveillance of Hepatitis A Virus Vaccine (Avaxim(®) 160U) in South Korea from 2011 to 2015
INTRODUCTION: Hepatitis A, caused by hepatitis A virus (HAV), is one of the leading causes of acute hepatitis in South Korea. Avaxim(®) 160U is an inactivated hepatitis A vaccine that has been proven to be highly effective and well tolerated. It is licensed for use in more than 90 countries, and was...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Healthcare
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6374234/ https://www.ncbi.nlm.nih.gov/pubmed/30673992 http://dx.doi.org/10.1007/s40121-019-0230-9 |